MOUNT PLEASANT, S.C., Jan. 23 /PRNewswire-FirstCall/ -- Revolutions Medical Corporation , is pleased to announce the successful completion of a 20 to 1 reverse stock split to create a better capital structure for its future growth strategy. The company is much better positioned now to raise the capital needed for product sales and marketing, and future product development. The name and symbol change was important too. It allows us to become more identified with the medical device and health care industry, as well as brand recognition for its current and future products.
"This was an enormous move forward for Revolutions Medical Corporation as we make the transition from a strictly R&D company to a company that is going into sales and marketing of its first products, while developing new products internally and through acquisition," stated Ron Wheet, President and CEO of Revolutions Medical Corporation. The company will also be improving investor relations and implementing more awareness campaigns for the company's stock and products as the new year progresses.
About Revolutions Medical Corporation:
Revolutions Medical Corporation operates in the safety-engineered medical devices (SEMDs) arena. Its products include the ReVac Safety Syringe, safety blood-drawing device and the ReVac Safety IV Catheter. The world market for SEMDs was projected to exceed $1.6 billion last year and is forecasted to maintain a 20% annual growth rate in the near term.
In the United States, the safety syringe market is expected to generate approximately $693 million in revenues in 2006, representing 66% of the total needles and syringes market. The Theta Report estimated the number of needles and syringes sold in the U.S. and International market combined should exceed 20 billion units in 2006.
Safe Harbor
Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.
Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.
Revolutions Medical CorporationCONTACT: Scott Key, Investor Relations, of Revolutions MedicalCorporation, +1-843-408-6265